Voyager Therapeutics Statistics
NASDAQ: VYGRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.53-0.08 (-4.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Voyager Therapeutics by the numbers
Voyager Therapeutics has a market capitalization of $95.2 million based on 62.23M shares outstanding. With trailing EPS of $-1.74, Voyager Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.8% below its 50-day average and 53.6% below its 200-day average.
Average daily trading volume is 770.24K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VYGR valuation vs. peer median
| Metric | VYGR | Peer median | Difference |
|---|---|---|---|
| Market cap | $95.21M | $96.62M | -1% |
| Avg. volume | 770.24K | 1.05M | -26% |
Peer median across 8 companies: OTLK, IPHA, MOLN, LENZ, ZURA, CRDL, FATE, ARMP.
Valuation
- Market cap
- $95.21M
- Price / sales (latest FY)
- 2.36
- EPS (TTM)
- $-1.74
- Shares outstanding
- 62.23M
Price and trading
- Previous close
- 1.61
- Open
- 1.57
- Day range
- 1.51 – 1.65
- 52-week range
- 1.48 – 5.48
- 52-week change
- -63.40%
- Beta
- —
- Volume
- 639.24K
- Average volume
- 770.24K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 95.21M
- Forward Pe
- -1.16
- Eps
- -1.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.48
- Week52 Low
- 1.48
- Avg Volume
- 770.24K
- Shares Outstanding
- 62.23M
- Ma50
- 2.21
- Ma200
- 3.30
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -72.08%
- Pct From52w Low
- 3.38%